Fritextsökning
Innehållstyper
-
Han blir ny vd på Praktikertjänst
Storkoncernen får ny topp.
-
New nano professor in Denmark
The Technical University of Denmark has appointed a recognized physicist as a new professor of miniaturized sensors.
-
Smuggling för miljarder
Läkemedel för 200 miljarder dollar - så stort är värdet på förfalskningsmarknaden visar en ny undersökning.
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Think outside the... brain
Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.
-
Grönt ljus för Pledpharma
Pledox försämrar inte effekten av cancerbehandlingen Folfox.
-
Lidds får USA-patent
Utökar skyddet för sin behandling mot prostatacancer.
-
Platelet analysis in whole blood
The new Multiplate analyzer from Triolab uses impedance aggregometry to measure the effects of platelet inhibitors on whole blood.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Control of blood vessels can treat obesity
Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet.
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
Recipharm investerar i Synthonics
Köper aktier för 17,6 miljoner och ingår samarbete med den amerikanska läkemedelstillverkaren.
-
Oslo Cancer Cluster
Cancer is, of course, the focus for this Oslo-based cluster, which is solely dedicated to cancer treatment and diagnostics. Oslo cancer cluster is also a part o...
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
Positivt i Isofol Medicals studie
Publicerar lovande resultat mot tjocktarmscancer och planerar fler studier.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Framåt för konsulterna
Kristina Eliason, Linda Tinelius och David Albenius är nya i life science-teamet på Hays, där efterfrågan på specialkompetenser ökar.
-
Motvind för Gilead
Medivirkonkurrentens hepatit C-läkemedel uppvisar oroande biverkningar.
-
Diamyd Medicals styrelse bemöter förslaget om likvidation
"De har gjort en dålig affär och vill ha pengarna tillbaka".
BREAKING